Dr. David Miklos, MD, PhD
Claim this profileStanford University, School of Medicine
Studies Non-Hodgkin's Lymphoma
Studies Mixed-Cell Lymphoma
10 reported clinical trials
16 drugs studied
Area of expertise
1Non-Hodgkin's Lymphoma
CD19 positive
BCL2 positive
BCL6 positive
2Mixed-Cell Lymphoma
CD19 positive
Affiliated Hospitals
Clinical Trials David Miklos, MD, PhD is currently running
Axicabtagene Ciloleucel
for Non-Hodgkin Lymphoma
This is a phase Ib study to establish safety of Axi-Cel-2 in patients with Large B Cell Lymphoma (LBCL) who are at high risk of relapse.
Recruiting1 award Phase 1
CAR T-Cell Therapy
for Brain Cancer
This is an open label, non-randomized, single site Phase I study to test the manufacturing feasibility and safety of locoregional (LR) administration of B7-H3CART into the central nervous system of adult subjects with recurrent IDH wild-type GBM using a standard 3+3 dose escalation design.
Recruiting1 award Phase 1
More about David Miklos, MD, PhD
Clinical Trial Related9 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments David Miklos, MD, PhD has experience with
- Cyclophosphamide
- CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells
- NKTR-255
- Fludarabine Phosphate
- Axicabtagene Ciloleucel
- Obinutuzumab
Breakdown of trials David Miklos, MD, PhD has run
Non-Hodgkin's Lymphoma
Mixed-Cell Lymphoma
Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Miklos, MD, PhD specialize in?
David Miklos, MD, PhD focuses on Non-Hodgkin's Lymphoma and Mixed-Cell Lymphoma. In particular, much of their work with Non-Hodgkin's Lymphoma has involved CD19 positive patients, or patients who are BCL2 positive.
Is David Miklos, MD, PhD currently recruiting for clinical trials?
Yes, David Miklos, MD, PhD is currently recruiting for 2 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that David Miklos, MD, PhD has studied deeply?
Yes, David Miklos, MD, PhD has studied treatments such as Cyclophosphamide, CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells, NKTR-255.
What is the best way to schedule an appointment with David Miklos, MD, PhD?
Apply for one of the trials that David Miklos, MD, PhD is conducting.
What is the office address of David Miklos, MD, PhD?
The office of David Miklos, MD, PhD is located at: Stanford University, School of Medicine, Palo Alto, California 94304 United States. This is the address for their practice at the Stanford University, School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.